Peter Fong joined Flagship Pioneering as senior principal in 2018. At Flagship, Peter leads a team of entrepreneurial scientists to develop the science, intellectual property, and business strategy that form the foundation of Flagship’s next breakthrough startups. In addition, he works closely with Flagship’s leadership on key initiatives and programs.
Peter brings extensive experience in biotechnology, new ventures, and research to Flagship Pioneering. Previously, Peter worked in oncology business development at Genentech. In this role, he focused on advancing Genentech’s immuno-oncology partnering efforts, which included leading the company’s $310M partnership with BioNTech for their neoantigen cancer vaccine. Peter has also worked at Memorial Sloan-Kettering, where he managed their New Ventures and Business Development group. Prior to Memorial, he also co-founded Carigent Therapeutics. Peter is an inventor on multiple issued patents and authored numerous scientific journal articles.
He received his Ph.D. in bioengineering from Yale University, where he also completed his postdoctoral training. His distinctions while at Yale include a Brown-Coxe Postdoctoral Fellowship. He received his B.S. in biochemistry from Indiana University.